NM_139343.3:c.715G>A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4BS1_Supporting

The NM_139343.3(BIN1):​c.715G>A​(p.Val239Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000424 in 1,613,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V239L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00038 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00043 ( 0 hom. )

Consequence

BIN1
NM_139343.3 missense

Scores

11
7

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:8O:1

Conservation

PhyloP100: 7.87

Publications

4 publications found
Variant links:
Genes affected
BIN1 (HGNC:1052): (bridging integrator 1) This gene encodes several isoforms of a nucleocytoplasmic adaptor protein, one of which was initially identified as a MYC-interacting protein with features of a tumor suppressor. Isoforms that are expressed in the central nervous system may be involved in synaptic vesicle endocytosis and may interact with dynamin, synaptojanin, endophilin, and clathrin. Isoforms that are expressed in muscle and ubiquitously expressed isoforms localize to the cytoplasm and nucleus and activate a caspase-independent apoptotic process. Studies in mouse suggest that this gene plays an important role in cardiac muscle development. Alternate splicing of the gene results in several transcript variants encoding different isoforms. Aberrant splice variants expressed in tumor cell lines have also been described. [provided by RefSeq, Mar 2016]
BIN1 Gene-Disease associations (from GenCC):
  • centronuclear myopathy
    Inheritance: AD, AR, SD Classification: DEFINITIVE, LIMITED Submitted by: ClinGen
  • myopathy, centronuclear, 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • autosomal dominant centronuclear myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.40762728).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000381 (58/152284) while in subpopulation AMR AF = 0.000981 (15/15298). AF 95% confidence interval is 0.000604. There are 0 homozygotes in GnomAd4. There are 30 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_139343.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BIN1
NM_139343.3
MANE Select
c.715G>Ap.Val239Ile
missense
Exon 9 of 19NP_647593.1O00499-1
BIN1
NM_001320642.1
c.634G>Ap.Val212Ile
missense
Exon 9 of 19NP_001307571.1O00499
BIN1
NM_001320641.2
c.622G>Ap.Val208Ile
missense
Exon 8 of 18NP_001307570.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BIN1
ENST00000316724.10
TSL:1 MANE Select
c.715G>Ap.Val239Ile
missense
Exon 9 of 19ENSP00000316779.5O00499-1
BIN1
ENST00000357970.7
TSL:1
c.715G>Ap.Val239Ile
missense
Exon 9 of 18ENSP00000350654.3O00499-5
BIN1
ENST00000346226.7
TSL:1
c.622G>Ap.Val208Ile
missense
Exon 8 of 16ENSP00000315411.3O00499-2

Frequencies

GnomAD3 genomes
AF:
0.000381
AC:
58
AN:
152166
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000982
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000441
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.000308
AC:
77
AN:
250268
AF XY:
0.000332
show subpopulations
Gnomad AFR exome
AF:
0.000124
Gnomad AMR exome
AF:
0.000261
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000460
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.000428
AC:
626
AN:
1461594
Hom.:
0
Cov.:
32
AF XY:
0.000441
AC XY:
321
AN XY:
727088
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33470
American (AMR)
AF:
0.000224
AC:
10
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.000499
AC:
43
AN:
86188
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53360
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.000473
AC:
526
AN:
1111922
Other (OTH)
AF:
0.000546
AC:
33
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
39
78
116
155
194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000381
AC:
58
AN:
152284
Hom.:
0
Cov.:
33
AF XY:
0.000403
AC XY:
30
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41556
American (AMR)
AF:
0.000981
AC:
15
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000830
AC:
4
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000441
AC:
30
AN:
68034
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000642
Hom.:
6
Bravo
AF:
0.000348
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000362
AC:
44
EpiCase
AF:
0.000436
EpiControl
AF:
0.000593

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
5
-
Myopathy, centronuclear, 2 (6)
-
3
-
not provided (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.41
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.23
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.26
T
Eigen
Uncertain
0.60
Eigen_PC
Uncertain
0.55
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.96
D
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.41
T
MetaSVM
Uncertain
-0.24
T
MutationAssessor
Uncertain
2.0
M
PhyloP100
7.9
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-0.98
N
REVEL
Uncertain
0.32
Sift
Benign
0.043
D
Sift4G
Benign
0.095
T
Polyphen
1.0
D
Vest4
0.68
MVP
0.82
MPC
0.83
ClinPred
0.14
T
GERP RS
4.6
Varity_R
0.37
gMVP
0.61
Mutation Taster
=34/66
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146573197; hg19: chr2-127821206; API